Simplex Trading’s Neos Therapeutics, Inc NEOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed 10560
2020
Q4
$0 Buy
+100
New +$62 ﹤0.01% 9432
2020
Q3
Sell
-66
Closed 8889
2020
Q2
$0 Hold
66
﹤0.01% 8727
2020
Q1
$0 Buy
+66
New +$91 ﹤0.01% 8594
2019
Q3
Sell
-1,706
Closed -$2K 8188
2019
Q2
$2K Buy
+1,706
New +$3.14K ﹤0.01% 6814
2018
Q4
Sell
-12,657
Closed -$35.5K 8188
2018
Q3
$61K Buy
12,657
+11,824
+1,419% +$67K ﹤0.01% 4977
2018
Q2
$5K Buy
+833
New +$6.21K ﹤0.01% 6754
2018
Q1
Sell
-8,125
Closed -$77.6K 7203
2017
Q4
$82K Sell
8,125
-4,808
-37% -$46.1K ﹤0.01% 1974
2017
Q3
$118K Buy
12,933
+10,242
+381% +$77.8K ﹤0.01% 1577
2017
Q2
$19K Buy
+2,691
New +$20.3K ﹤0.01% 3371

Simplex Trading's NEOS Position: Q1 2021 in Review

Simplex Trading sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 100 shares.

Simplex Trading first reported a position in NEOS in Q2 2017 and held it in 9 quarters. The position peaked at $118K in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

  • Simplex Trading reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Simplex Trading sold 100 Neos Therapeutics, Inc shares in Q1 2021.
  • Simplex Trading first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 9 quarters.
  • Simplex Trading's Neos Therapeutics, Inc position peaked at $118K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.